Cargando…
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas
Nonglioblastomatous diffuse glioma (non‐GDG) is a heterogeneous neuroepithelial tumor that exhibits a varied survival range from 4 to 13 years based on the diverse subtypes. Recent studies demonstrated novel molecular markers can predict prognosis for non‐GDG patients; however, these findings as wel...
Autores principales: | Wu, Wei, Wang, Yichang, Niu, Chen, Wahafu, Alafate, Huo, Longwei, Guo, Xiaoye, Xiang, Jianyang, Li, Xiaodong, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819305/ https://www.ncbi.nlm.nih.gov/pubmed/34866280 http://dx.doi.org/10.1111/cas.15233 |
Ejemplares similares
-
FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
por: Wang, Yichang, et al.
Publicado: (2021) -
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022) -
A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022) -
Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020) -
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
por: Alafate, Wahafu, et al.
Publicado: (2020)